The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127567761 12756776 1 I 20150328 20150519 20160917 20160917 EXP JP-AMGEN-JPNCT2015052571 AMGEN 66.00 YR E M Y 60.60000 KG 20160917 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127567761 12756776 1 PS panitumumab PANITUMUMAB 1 Intravenous drip 6 MG/KG, Q2WK 16.1860466 MG/KG Y U 125147 6 MG/KG SOLUTION FOR INJECTION QOW
127567761 12756776 2 SS panitumumab PANITUMUMAB 1 Intravenous drip 6 MG/KG, Q2WK 16.1860466 MG/KG Y U 125147 6 MG/KG SOLUTION FOR INJECTION QOW
127567761 12756776 3 SS panitumumab PANITUMUMAB 1 Intravenous drip 6 MG/KG, Q2WK 16.1860466 MG/KG Y U 125147 6 MG/KG SOLUTION FOR INJECTION QOW
127567761 12756776 4 SS panitumumab PANITUMUMAB 1 Intravenous drip UNK UNK, Q2WK 16.1860466 MG/KG Y U 125147 SOLUTION FOR INJECTION QOW
127567761 12756776 5 SS LOXOPROFEN EMEC LOXOPROFEN 1 Oral 60 MG, BID 5880 MG U 0 60 MG BID
127567761 12756776 6 SS 5-FU FLUOROURACIL 1 Intravenous bolus 400 MG/M2, Q2WK 7553.48828 MG/M2 U 0 400 MG/M**2 QOW
127567761 12756776 7 SS 5-FU FLUOROURACIL 1 Intravenous drip 2400 MG/M2, Q2WEEKS 7553.48828 MG/M2 U 0 2400 MG/M**2 QOW
127567761 12756776 8 SS 5-FU FLUOROURACIL 1 Intravenous bolus 400 MG/M2, Q2WEEKS 7553.48828 MG/M2 U 0 400 MG/M**2 QOW
127567761 12756776 9 SS 5-FU FLUOROURACIL 1 Intravenous drip 2400 MG/M2, Q2WEEKS 7553.48828 MG/M2 U 0 2400 MG/M**2 QOW
127567761 12756776 10 SS 5-FU FLUOROURACIL 1 Intravenous (not otherwise specified) UNK UNK, Q2WEEKS 7553.48828 MG/M2 U 0 QOW
127567761 12756776 11 SS OXALIPLATIN. OXALIPLATIN 1 Intravenous drip 85 MG/M2, Q2WEEKS 229.302322 MG/M2 U 0 85 MG/M**2 QOW
127567761 12756776 12 SS OXALIPLATIN. OXALIPLATIN 1 Intravenous drip 85 MG/M2, Q2WEEKS 229.302322 MG/M2 U 0 85 MG/M**2 QOW
127567761 12756776 13 C CALCIUM LEVOFOLINATE LEVOLEUCOVORIN CALCIUM 1 Intravenous drip 200 MG/M2, Q2WEEKS 800 MG/M2 U 0 200 MG/M**2 QOW
127567761 12756776 14 C CALCIUM LEVOFOLINATE LEVOLEUCOVORIN CALCIUM 1 Intravenous drip 200 MG/M2, Q2WEEKS 800 MG/M2 U 0 200 MG/M**2 QOW
127567761 12756776 15 C OXYCODONE OXYCODONE 1 Oral 5 MG, BID 410 MG U 0 5 MG BID
127567761 12756776 16 C OXYCODONE OXYCODONE 1 Oral 5 MG, BID 410 MG U 0 5 MG BID
127567761 12756776 17 C REBAMIPIDE REBAMIPIDE 1 Oral 100 MG, BID U 0 100 MG BID
127567761 12756776 18 C REBAMIPIDE REBAMIPIDE 1 Oral 100 MG, BID U 0 100 MG BID
127567761 12756776 19 C MINOCYCLINE HYDROCHLORIDE. MINOCYCLINE HYDROCHLORIDE 1 Oral 100 MG, BID 11000 MG U 0 100 MG BID
127567761 12756776 20 C KYTRIL GRANISETRON HYDROCHLORIDE 1 Oral 2 MG, UNK U 0 2 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127567761 12756776 1 Rectal cancer
127567761 12756776 5 Cancer pain
127567761 12756776 6 Rectal cancer
127567761 12756776 11 Rectal cancer
127567761 12756776 13 Rectal cancer
127567761 12756776 15 Cancer pain
127567761 12756776 17 Prophylaxis against gastrointestinal ulcer
127567761 12756776 19 Dermatitis acneiform
127567761 12756776 20 Nausea

Outcome of event

Event ID CASEID OUTC COD
127567761 12756776 HO
127567761 12756776 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127567761 12756776 Alanine aminotransferase increased
127567761 12756776 Amylase increased
127567761 12756776 Anaemia
127567761 12756776 Anal haemorrhage
127567761 12756776 Aspartate aminotransferase increased
127567761 12756776 Blood alkaline phosphatase increased
127567761 12756776 Decreased appetite
127567761 12756776 Dermatitis acneiform
127567761 12756776 Dry skin
127567761 12756776 Fatigue
127567761 12756776 Gamma-glutamyltransferase increased
127567761 12756776 Gastric ulcer haemorrhage
127567761 12756776 Gastrointestinal stoma complication
127567761 12756776 Hypoalbuminaemia
127567761 12756776 Hypocalcaemia
127567761 12756776 Hypomagnesaemia
127567761 12756776 Nausea
127567761 12756776 Palmar-plantar erythrodysaesthesia syndrome
127567761 12756776 Paronychia
127567761 12756776 Peripheral sensory neuropathy
127567761 12756776 Seborrhoeic dermatitis
127567761 12756776 Skin hyperpigmentation
127567761 12756776 Stomatitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127567761 12756776 1 20150326 20150507 0
127567761 12756776 2 20150611 20160510 0
127567761 12756776 3 20160609 20160609 0
127567761 12756776 4 20160707 0
127567761 12756776 5 20150306 20150519 0
127567761 12756776 6 20150326 20150507 0
127567761 12756776 7 20150326 20150507 0
127567761 12756776 8 20150611 20160609 0
127567761 12756776 9 20150611 20160609 0
127567761 12756776 10 20160707 0
127567761 12756776 11 20150326 20150507 0
127567761 12756776 12 20150611 20150625 0
127567761 12756776 13 20150326 20150507 0
127567761 12756776 14 20150611 20160609 0
127567761 12756776 15 20150409 20150519 0
127567761 12756776 16 20150526 0
127567761 12756776 17 20150519 0
127567761 12756776 18 20150527 0
127567761 12756776 19 20150326 20150519 0
127567761 12756776 20 20150507 20150519 0